2018 CITO Winter Symposium
The Center for Immunotherapeutic Transport Oncophysics (CITO) is a multidisciplinary collaboration funded by a $9M award from the Physical Sciences-Oncology Network of the National Cancer Institute. The CITO comprises several key institutional partners including the Houston Methodist Research Institute, the University of Texas M.D. Anderson Cancer Center, the University of Texas Southwestern Medical Center, the Moffitt Cancer Center, the Dana-Farber Cancer Institute, and the Mayo Clinic. Our overarching goal is to apply the principles of physics toward designing effective immunotherapies. Immunotherapy is a promising treatment option for many cancer patients. However, immunotherapy is not effective in all types of cancers, in particular, breast and pancreatic cancer, and in many metastasized cancers. In the CITO, we seek to understand the physical transport and biophysical phenomena of immune cells and immunotherapeutics, both systemic and within the tumor microenvironment, to determine their role in developing more effective and personalized cancer immunotherapeutic strategies. We are also committed to working closely with patient advocates to ensure that our research aligns with potential, future clinical translation. The 2018 CITO Winter Symposium serves to foster collaboration and dialogue for the study of transport-based cancer immunotherapies and to provide a platform through which CITO members can engage with the broader scientific community about the role of the physical sciences in cancer research and patient-centered care. Please join us to learn about exciting new developments in the field and to honor the hard work of our dedicated patient advocacy network.